Results of a new European study published in the Journal of Parkinson's Disease may help improve clinical practice by shedding light on the lives of people with PD and their caregivers, re-emphasizing the many challenges ...
Sep 1, 2021
0
5
Patients with Parkinson's disease (PD) are at higher risk for vaccine-preventable respiratory illnesses. However, patients with advanced PD may have less access to vaccinations according to a new study published in the Journal ...
Aug 30, 2021
0
2
It is well known that dementia is associated with increased mortality. New scientific research shows how in recent years more deaths are being registered with dementia as the underlying cause of death. The growth in the rate ...
Aug 25, 2021
0
3
The COVID-19 pandemic has significantly altered the delivery of health care including neuropsychological evaluations. Telehealth procedures may become a standard feature in healthcare after the crisis has resolved. In a mini-forum ...
Aug 6, 2021
0
11
Huntington's Disease (HD) is a progressive neurodegenerative condition characterized by motor, cognitive, and psychiatric symptoms, and motor symptoms are often preceded by cognitive changes. Recent evidence indicates that ...
Jul 15, 2021
0
2
Mass spectrometry has emerged as an important analytical tool for gaining a better understanding of mechanisms underlying Huntington's disease (HD), alongside the increased availability of cell and animal models of the disease. ...
Jul 13, 2021
0
6
There is growing awareness that air pollutants are playing a critical role in the development of neurodegenerative diseases. A new book, Alzheimer's Disease and Air Pollution: The Development and Progression of a Fatal Disease ...
Jun 22, 2021
0
2
The Treatabolome project is a research initiative to develop a freely available, interoperable online platform dedicated to disseminating rare disease and gene-specific treatment information to healthcare professionals regardless ...
Jun 1, 2021
0
1
It is projected that up to 152 million people worldwide will be living with Alzheimer's disease (AD) by 2050. To date there are no drugs that have a substantial positive impact on either the prevention or reversal of cognitive ...
May 11, 2021
0
65
The clinical presentation and underlying biology of Parkinson's disease (PD) varies significantly, but attempts to cluster cases into a limited number of subtypes have questionable applicability and relevance, reports the ...
Apr 29, 2021
0
1
